Dr. Marlow Hernandez - 03 Jan 2023 Form 4 Insider Report for Cano Health, Inc.

Role
CEO, Director
Signature
/s/ David J. Armstrong, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
03 Jan 2023
Net transactions value
+$116,750
Form type
4
Filing time
05 Jan 2023, 15:05:51 UTC
Previous filing
07 Jul 2022
Next filing
04 Apr 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CANO Class A Common Stock Award $116,750 +134,660 +3.8% $0.8670 3,680,910 03 Jan 2023 Direct F1
holding CANO Class A Common Stock 67,597 03 Jan 2023 See Footnote F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person is voluntarily reporting the acquisition of shares of the Issuer's Class A common stock under the Cano Health, Inc. 2021 Employee Stock Purchase Plan in a transaction that is exempt under both Rule 16b-3(d) and Rule 16b-3(c).
F2 These shares are held indirectly by the Reporting Person through the Marlow B. Hernandez 2020 Family Trust.